Clinical Trials Browser

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07389239 2026-02-20

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Phase 1/2 Not yet recruiting

24 enrolled

Gynecologic

Ovarian Neoplasms

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Phase 1 Not yet recruiting

15 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07183852 2025-09-19

GoTIL-01

Phase 1 Not yet recruiting

18 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT07105176 2025-08-19

HS-IT101 Injection for Advanced NSCLC

Phase 1 Not yet recruiting

12 enrolled

Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05810792 2023-11-22

PANCEP-1

Phase 2 Not yet recruiting

50 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05903937 2023-06-15

HAITILS-PHP

Phase 1 Not yet recruiting

6 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

30 enrolled

Other solid neoplasm

Solid Tumors

Clinical Trials

RIOT 4B

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

GoTIL-01

HS-IT101 Injection for Advanced NSCLC

PANCEP-1

HAITILS-PHP

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors